Skip to content

Deep Brain Stimulation of the Bilateral Nucleus Accumbens for Patients With Methadone Maintenance Treatment

Deep Brain Stimulation of the Bilateral Nucleus Accumbens for Patients With Methadone Maintenance Treatment

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03952455
Enrollment
12
Registered
2019-05-16
Start date
2019-05-13
Completion date
2021-06-01
Last updated
2020-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction Opiate

Keywords

Nucleus Accumbens, Deep brain stimulation, Methadone

Brief summary

Methadone maintenance treatment (MMT) is one of the main forms of treatments for opioid dependence. Despite its effectiveness and widespread use, people will experience withdrawal if daily dose is insufficient or missed, promoting reluctance to attempt detoxification. In addition, methadone is a full opioid agonist which can induce respiratory depression or sedation without ceiling level, so overdose usage can be fatal. Hence, an alternative therapy is needed to completely reduce the carving for drugs and to relieve the negative affective sate caused by withdrawal. Deep brain stimulation (DBS) is a reasonable treatment approach for addiction. Since 2009 the first case report emerged, the nucleus accumbens (NAc) is still the only brain target to be investigated in clinical case series of DBS for alcohol and heroin addiction. This research will mainly investigate the effectiveness and safety of NAc-DBS for patients with methadone maintenance treatment. The investigators will also explore the influence of NAc-DBS on brain activity and cognition.

Interventions

PROCEDUREBilateral surgical implantation of DBS system to Nucleus Accumbens

We plan to use the SceneRay 1242 (SceneRay, SuZhou, China) electrode with a diameter of 1.27 mm and 4 contacts. The SceneRay 1242 electrode combined with the SceneRay 1181 implantable pulse generator has the advantage of adaptive coverage area for the Ventral Capsule/Ventral Striatum, enabling simultaneous implantation in the nucleus accumbens (NAc; 2 ventral contacts) and the anterior limb of the internal capsule (ALIC; 2 dorsal contacts) with independently programmed parameters such as frequency, amplitude, and voltage; and remote and wireless programing, which allows for convenient and prompt adjustments in emergency situations. The contact length is 3.0 mm and the spacings between the ventral and dorsal contacts are 2 mm, 4 mm, and 4 mm, respectively, spanning a total length of 22.5 mm (3 + 2 + 3 + 4 + 3 + 4 + 3 mm, with 0.5 mm projecting from the electrode tip).

Sponsors

Ruijin Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* MINI diagnosis of substance dependence; * Proficiency in Mandarin language; * Failure to detox more than three times; * Long-term methadone maintenance treatment; * Capacity to provide informed consent (understanding of the study purpose and methods);

Exclusion criteria

* Schizophrenia(MINI diagnosis); * Antisocial personality disorder(MINI diagnosis); * Contraindications of a MRI-examination, e.g. implanted cardiac pacemaker/heart defibrillator; * Severe cognitive impairments(MoCA ≤ 22); * Enrollment in other clinical trials; * Stereotactic respectively neurosurgical intervention in the past; * Contraindications of stereotactic intervention, e.g. increased bleeding disposition, cerebrovascular diseases (e.g. arteriovenous malfunction, aneurysms, systemic vascular diseases); * Serious or instable organic diseases (e.g. instable coronal heart disease); * Tested positively for HIV; * Pregnancy and/or lactation; * Epilepsy or other severe brain trauma or neurological impairments;

Design outcomes

Primary

MeasureTime frameDescription
Changes in Methadone doseBaseline (preoperative),1 month, 3 months,6 months,9 months, 12 monthsThe volume of daily methadone the patients used.

Secondary

MeasureTime frameDescription
Hamilton Depression Scale(HAMD-17)Baseline(preoperative),1 month, 3 months, 6 months, 9 months, 12 months17 items, Total scores\<7: normal; 7\<Total scores≤17: possible depression; 17\<Total scores≤24: definite depression; Total score\>24: severe depression
Hamilton Anxiety Scale (HAMA)Baseline(preoperative),1 month, 3 months, 6 months,9 months, 12 months14 items, Total scores\<6: normal; 7\<Total scores≤14: possible anxiety; 14\<Total scores≤21:definite anxiety; Total score\>21: severe anxiety
Young Manic Rating Scale (YMRS)Baseline(preoperative),1 month, 3 months, 6 months,9 months, 12 monthsThe Young Mania Rating Scale (YMRS) is one of the most frequently utilized rating scales to assess manic symptoms. The scale has 11 items and is based on the patient's subjective report of his or her clinical condition.
Monitoring of Side Effects Scale (MOSES)Baseline(preoperative),1 month, 3 months, 6 months,9 months, 12 monthsTo evaluate side effects. The higher score means more severity of side effects.
Changes in Subjective Opiate Withdrawal Scale(SOWS)Baseline(preoperative),1 month, 3 months, 6 months,9 months, 12 monthsSubjective Opiate Withdrawal Scale is a 16-item self-reported scale assessing severity of opiate withdrawal. Each item is rated on a 5-point Likert scale, ranging form 0(not at all) to 4(extremely).
Obsessive compulsive drug use scale(OCDUS)Baseline(preoperative),1 month, 3 months, 6 months,9 months, 12 monthsObsessive compulsive drug use scale is a 13-item self-rating scale measuring opiate craving. The total score ranges from 0 to 52. The higher score indicates stronger carving.
The MOS item short from health survey (SF-36)Baseline(preoperative),1 month, 3 months,6 months,9 months, 12 months36 items. To evaluate the quality of life and the higher score indicates better quality of life.
World Health Organization Quality of Life-BREF (WHO-BREF)Baseline(preoperative),1 month, 3 months,6 months,9 months, 12 months26 items. The higher score means the better quality of life.
Cognitive performanceBaseline(preoperative),6 months,12 monthsCognitive performance is measured by a series of tasks which include stop signal task, paired associated memory, spatial working memory, stocking of Cambridge, intra-extra dimensional set shift, Bart, Beads, Delay discounting task, model-based and model-free task, avoid-approach task, dot-probe task, drug rating task.
Brain activityBaseline(preoperative), 6 months,12 monthsPET(Positron Emission Tomography) or fMRI(functional Magnetic Resonance Imaging) are used in this study.
Fagerstrom Test for Nicotine Dependence assessment (FTND)Baseline(preoperative),1 month, 3months,6months,9 months, 12 monthsTo evaluate Nicotine Dependence. The higher of scores indicates higher level of Nicotine Dependence
Beck depression inventory(BDI)Baseline(preoperative),1 month, 3months,6months,9 months, 12 monthsThe BDI contains 21 questions, each answer scored on a scale value of 0 to 3. 0-13: minimal depression;14-19:mild depression; 20-28:moderate depression; and 29-63:severe depression. Higher total score indicate more severe depressive symptoms.
Beck anxiety inventory(BAI)Baseline(preoperative),1 month, 3months,6months,9 months, 12 monthsThe BAI contains 21 questions, each answer scored on a scale value of 0 to 3. 0-21: mild anxiety;22-35: moderate anxiety;36-63:severe anxiety. Higher total score indicate more severe anxiety symptoms.
Perceived stress scale(PSS-10)Baseline(preoperative),1 month, 3months,6months,9 months, 12 monthsThe PSS-10 is a classic stress assessment instrument. Each item is rated on a 5-likert scale ranging form 0(never) to 4(often). Higher score indicate more severity of stress symptom.
Twenty Item Positive and Negative Affect Schedule (PANAS)Baseline(preoperative),1 month, 3months,6months,9 months, 12 monthsThe PANAS contains two subscales: positive and negative subscale. Each item is rated on a 5-likert scale ranging from 1(Not at all) to 5(severely, it bothered me a lot).
Work and Social Adjustment Scale(WSAS)Baseline(preoperative),1 month, 3months,6months,9 months, 12 monthsSelf-rated scale. The maximum score of the WSAS is 40, lower scores are better.

Other

MeasureTime frameDescription
Barratt impulsiveness scaleBaseline(preoperative)The Barratt Impulsiveness Scale is a questionnaire designed to assess the personality/behavioral construct of impulsiveness which is composed of 30 items describing common impulsive or non-impulsive (for reverse scored items) behaviors and preferences. It has three 2nd order facets which are attentional, motor and non-planning. Each facet has 10 items. Higher score means greater impulsivity.
UPPS-P impulsive behavior scaleBaseline(preoperative)The UPPS-P Impulsive Behavior Scale is a 59-item questionnaire assessing impulsive personality traits. Each item is rated on a 4-point scale ranging from 1 (agree strongly) to 4 (disagree strongly) to indicate subject's agreement with statements. This scale includes the following five subscales: negative urgency (NU), lack of premeditation (LPM), lack of perseverance (LPS), sensation seeking (SS) and positive urgency (PU). Higher score represents a greater level of impulsivity.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026